# CSRNP2

## Overview
CSRNP2, or cysteine and serine rich nuclear protein 2, is a gene that encodes a protein of the same name, which is part of the cysteine-serine-rich nuclear protein family. This protein is primarily localized in the nucleus and is implicated in transcriptional regulation, potentially functioning as a transcription factor due to its ability to bind DNA (Gingras2007Characterization). The protein is characterized by a serine-rich amino-terminal region and a cysteine-rich domain, which are indicative of its role in DNA binding and transcriptional activity. CSRNP2 is expressed in various human tissues, including the brain, ovary, and thymus, suggesting its involvement in a range of physiological processes (Zhang2021The). Although its precise functions in normal cellular processes are not fully understood, CSRNP2 has been associated with immune response and chromatin dynamics, and it has been identified as a prognostic biomarker in certain cancers, such as clear cell renal cell carcinoma (Gingras2007Characterization; Zhang2021The).

## Function
CSRNP2, a member of the cysteine-serine-rich nuclear protein family, is primarily active in the nucleus and is involved in transcriptional regulation. It is characterized by a serine-rich amino-terminal region and a cysteine-rich region with conserved cysteine residues, which suggests a role in DNA binding and transcriptional activity (Gingras2007Characterization). CSRNP2 has been identified as a potential transcription factor due to its nuclear localization and ability to bind DNA, with a specific binding sequence identified as AGAGTG (Gingras2007Characterization).

In healthy human cells, CSRNP2 is expressed in various tissues, including the brain, ovary, and thymus, indicating its involvement in diverse physiological processes (Zhang2021The). Despite its potential roles, the exact function of CSRNP2 in normal cellular processes remains unclear, as studies have not observed significant phenotypic changes in CSRNP2-deficient mice, suggesting possible redundancy with other genes (Gingras2007Characterization). However, CSRNP2 has been linked to increased susceptibility to influenza infection, indicating a role in immune response (Gingras2007Characterization). The protein's involvement in transcriptional regulation and cellular stress responses suggests it contributes to normal cellular function and development.

## Clinical Significance
CSRNP2 has been identified as a prognostic biomarker in clear cell renal cell carcinoma (ccRCC). Alterations in the expression levels of CSRNP2, along with other members of the CSRNP gene family, have been linked to the prognosis of ccRCC. Specifically, higher expression of CSRNP2 is associated with a higher risk group, correlating with poorer overall survival in patients with a high-mutant burden (Zhang2021The). Genetic alterations in CSRNP2, such as missense and truncating mutations, have been analyzed, although these alterations are relatively rare, occurring in approximately 0.2% of cases (Zhang2021The).

CSRNP2 is also involved in pathways related to immune response and inflammation, which may contribute to its role in ccRCC. The gene's expression is positively associated with effector memory CD4 T cells in tumor tissues, suggesting a potential link between CSRNP2 expression and immune infiltration in cancer (Zhang2021The). Despite its lower mRNA expression in ccRCC compared to normal tissues, CSRNP2's expression does not significantly differ across different stages of the disease, nor is it significantly associated with overall survival in the general ccRCC patient population (Zhang2021The).

## Interactions
CSRNP2 (cysteine and serine rich nuclear protein 2) is involved in various protein interactions that suggest its role in chromatin structure and function. Cross-linking mass spectrometry studies have identified CSRNP2 as being cross-linked to histone proteins, indicating that it may associate with histones through proximal binding to DNA rather than direct binding to the histones themselves. This suggests a potential role for CSRNP2 in modulating chromatin dynamics and gene expression by interacting with DNA-bound histones (Ser2019Optimized).

In the context of Alzheimer's disease, CSRNP2 is noted for its high connectivity within the Alzheimer's disease subregulatory network, although specific physical interactions with other proteins or nucleic acids in this context are not detailed. This highlights its potential importance in the molecular mechanisms underlying the disease (Vargas2018Alzheimer’s).

Additionally, CSRNP2 has been identified as a candidate gene for obesity, with a significant differential expression percentage, but specific interactions with proteins or nucleic acids in this context are not provided (Chen2013Identifying). Overall, CSRNP2's interactions suggest its involvement in critical cellular processes, particularly related to chromatin and transcription regulation.


## References


[1. (Vargas2018Alzheimer’s) D. M. Vargas, M. A. De Bastiani, E. R. Zimmer, and F. Klamt. Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates. Alzheimer’s Research &amp; Therapy, June 2018. URL: http://dx.doi.org/10.1186/s13195-018-0394-7, doi:10.1186/s13195-018-0394-7. This article has 70 citations.](https://doi.org/10.1186/s13195-018-0394-7)

[2. (Ser2019Optimized) Zheng Ser, Paolo Cifani, and Alex Kentsis. Optimized cross-linking mass spectrometry for in situ interaction proteomics. Journal of Proteome Research, 18(6):2545–2558, May 2019. URL: http://dx.doi.org/10.1021/acs.jproteome.9b00085, doi:10.1021/acs.jproteome.9b00085. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jproteome.9b00085)

[3. (Chen2013Identifying) Junhui Chen, Yuhuan Meng, Jinghui Zhou, Min Zhuo, Fei Ling, Yu Zhang, Hongli Du, and Xiaoning Wang. Identifying candidate genes for type 2 diabetes mellitus and obesity through gene expression profiling in multiple tissues or cells. Journal of Diabetes Research, 2013:1–9, 2013. URL: http://dx.doi.org/10.1155/2013/970435, doi:10.1155/2013/970435. This article has 74 citations and is from a peer-reviewed journal.](https://doi.org/10.1155/2013/970435)

[4. (Gingras2007Characterization) Sébastien Gingras, Stéphane Pelletier, Kelli Boyd, and James N. Ihle. Characterization of a family of novel cysteine- serine-rich nuclear proteins (csrnp). PLoS ONE, 2(8):e808, August 2007. URL: http://dx.doi.org/10.1371/journal.pone.0000808, doi:10.1371/journal.pone.0000808. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0000808)

[5. (Zhang2021The) Huaru Zhang, Xiaofu Qiu, and Guosheng Yang. The csrnp gene family serves as a prognostic biomarker in clear cell renal cell carcinoma. Frontiers in Oncology, March 2021. URL: http://dx.doi.org/10.3389/fonc.2021.620126, doi:10.3389/fonc.2021.620126. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.620126)